BrainAurora Medical Technology Limited (HKG:6681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.440
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT

HKG:6681 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-314.86-198.28-359.08-502.45-697.84
Depreciation & Amortization
25.5226.272112.361.55
Other Amortization
0.660.880.270.070.08
Loss (Gain) From Sale of Assets
0.06-00.060.13-0.01
Loss (Gain) From Sale of Investments
-1.12-0.01-2.67-3.24-
Stock-Based Compensation
77.2166.7744.87-19.37
Provision & Write-off of Bad Debts
38.9211.480.850.050.01
Other Operating Activities
16.55-14.27183.54401.2628.83
Change in Accounts Receivable
-27.91-64.45-48.01-11.79-6.01
Change in Accounts Payable
-3.6612.3323.442.074.85
Change in Unearned Revenue
10.069.682.710.720.39
Change in Other Net Operating Assets
0.533.56-3.840.21-0.44
Operating Cash Flow
-178.03-146.04-136.87-100.68-49.21
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-14.31-17.33-15.97-16.4-10.8
Sale of Property, Plant & Equipment
0.570.070.250.020.01
Sale (Purchase) of Intangibles
-13.4-0.37-2.05-2.66-0.02
Investment in Securities
-203.030.01333.46-327.55-
Other Investing Activities
-20.72144.91-212.642.63-1.17
Investing Cash Flow
-272.89123.38102.55-334.46-21.48

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
348.92335.04156.96-
Long-Term Debt Issued
---50350
Total Debt Issued
348.92335.041556.96350
Short-Term Debt Repaid
-25-15-2.36--4.09
Long-Term Debt Repaid
-101.37-8.26-7.95-6.25-0.81
Total Debt Repaid
-126.37-23.26-10.31-6.25-4.89
Net Debt Issued (Repaid)
222.56311.784.6950.71345.11
Issuance of Common Stock
218.2-153.1289.563.7
Other Financing Activities
-101.49-2.98-94.28-0.57-15.19
Financing Cash Flow
339.27308.8163.53139.65393.61

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.130.160.120.01-
Net Cash Flow
-118.78286.3129.33-295.49322.93

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-192.34-163.37-152.84-117.08-60.01
Free Cash Flow Growth
-----
Free Cash Flow Margin
-87.41%-133.57%-227.44%-1036.94%-2610.05%
Free Cash Flow Per Share
-0.16-0.16-0.26-0.42-0.40
Levered Free Cash Flow
-145.648.4-252.93-82.34-
Unlevered Free Cash Flow
-130.6522.17-240.29-70.32-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
80.151.020.630.570.19
Cash Income Tax Paid
1.250.05---
Change in Working Capital
-20.98-38.88-25.71-8.8-1.2